Team Member

Marijke is a cardiology resident who began her training in 2024, combining clinics with research. In addition, she is pursuing a Postgraduate Master’s in Clinical Epidemiology at Utrecht University.

Her research primarily focuses on cardio-oncology, a subspecialty that explores the interplay between cancer and cardiovascular disease. She is particularly focused on reducing the cardiovascular risks associated with cancer treatments, emphasizing risk stratification to identify patients most vulnerable to cardiovascular complications. Her work also involves developing and implementing strategies to mitigate these risks, aiming to improve the tolerability of cancer treatments and enhance long-term outcomes for cancer patients and survivors. Marijke serves as co-PI and cardiology lead for the HOVON 170 DLBCL – ANTICIPATE trial.

Since the COVID-19 pandemic, her research has expanded to include the study of short- and long-term cardiovascular complications related to COVID-19, in patients with and without pre-existing heart conditions.

Marijke has received funding from the Dutch Heart Foundation, Dutch Cancer Society, and ZonMw, and has (co-)founded several research consortia, including ANTICIPATE, CAPACITY, and DEFENCE.